The Health Service Executive (HSE) has decided to make a life-saving Soliris drug available to Irish patients despite criticising its “exorbitant” and ‘astronomical’ cost.

A life-saving drug which costs about €430,000 per patient annually is to be made available in Ireland, even though the Health Service Executive (HSE) (...)

Minister for Health Leo Varadkar says it is regrettable Alexion  has failed  to provide a potentially life-saving drug to Irish patients at a more sustainable price. Photograph: Alan Betson/The Irish Times

The Minister for Health has strongly attacked a leading US pharmaceutical company over its “aggressive” pricing policy.Leo Varadkar said it was regre(...)

Minister for Health Leo Varadkar: ‘It is regrettable that to date the company has not been able to provide this drug at a more sustainable price to the HSE to reflect the clinical evidence.’ Photograph: Morgan Treacy/Inpho

The HSE is considering the outcome of talks with a company on the purchase of a drug to treat paroxysmal nocturnal haemoglobinuria (PHN), Minister fo(...)

Anne MacMahon from Kilcornan, Co Limerick: she also has PNH but four years on from being treated with Soliris, she enjoys a vastly improved quality of life. Photograph: Don Moloney/Press 22

Mary Gorman and Anne MacMahon, both in their 50s and living in rural Ireland, have the same rare, life-threatening blood disorder. One of these women (...)

Traders are pictured at their desks in front of the DAX board at the Frankfurt stock exchange yesterday.The  DAX Index climbed 0.3 per cent. Photograph: Reuters

National benchmark indices advanced in nine of the 18 western-European markets yesterday. Germany’s DAX Index climbed 0.3 per cent and France’s CAC 4(...)

Dan Flinter: chairs the PM Group as well as being chairman of the board of ‘The Irish Times’.

PM Group, the Dublin group that provides construction, engineering and project management services to multinationals worldwide, last year recorded a s(...)

The UCD Michael Smurfit Graduate Business School will host a lecture series on the business of biotechnology on October 14th

On October 14th, the UCD Michael Smurfit Graduate Business School will play host to the Laurence Crowley lecture series on the business of biotechnolo(...)

Pedestrians pass in front of the Nasdaq MarketSite in New York, US. Photograph: Scott Eells/Bloomberg

For much of the past year, Tesla Motors seemingly could do no wrong in investors’ eyes. A nearly unbroken string of quarterly losses, amb(...)

Rare disease specialist Alexion has announced another €75 million investment in Ireland, creating a further 200 jobs. (...)

Alexion, which recently hired  Julie O’Neill (above) to head its Irish business, is looking to build a five-storey office block on a 16.8 hectare site in Blanchardstown, in west Dublin.

Ultra-rare disease specialist Alexion has submitted an application for a proposed headquarters in College Park in Blanchardstown, in west Dubli(...)